by activating a family of receptors collectively known as bile acid-activated receptors (BARs). BARs belong to the superfamilies of G protein (GP)-coupled receptors and nuclear receptors (10, 20) . The best characterized BARs in these two families are the GPBAR1 (also known as TGR5) and the farnesoid-x-receptor (FXR) (10, 11) . GPBAR1 is a cell surface receptor highly expressed by nonparenchymal liver cells (14) , enterocytes, and endocrine intestinal cells (10, 20) , and it is thought to mediate nongenomic activities of bile acids by causing the recruitment of cAMP response element binding protein (CREB) to target genes endowed with a CRE responsive element. In addition, GPBAR1 is expressed in neurons in the central and peripheral nervous system and is the putative mediator of perception of itching and pain induced by bile acids (20, 21) . One specific feature of GPBAR1 is its expression by liver sinusoidal and vascular endothelial cells suggesting a role for this receptor in regulating the liver and systemic microcirculation (14, 17) . In addition, GPBAR1 is expressed by smooth muscle cells and regulates smooth muscle relaxation via inhibition of Rho kinase pathway (27) .
Gaseous mediators, nitric oxide (NO) and hydrogen sulfide (H 2 S), are potent vasoregulatory agents located downstream to several signaling pathways in the vascular system. Previous studies have shown that BARs regulate NO and H 2 S generation through an overlapping network of genomic and nongenomic effects (2, 3, 5, 19, 23, 24, 34, 37) . Thus, while activation of GPBAR1 by natural and synthetic ligands modulates the expression/activity of endothelial NO synthase (eNOS) (6, 23) in liver sinusoidal and endothelial cells (5, 23) , activation of FXR increases the expression/activity of cystathionine-␥-lyase (CSE), an enzyme that is central in the "trans-sulfuration pathway," which leads to generation of H 2 S (29). An impairment of CSE expression/activity supports the alterations of the trans-sulfuration pathway that occurs in liver cirrhosis, leading to a combination of hyper-homocysteinemia and reduced generation of H 2 S within the liver microcirculation, translating into an enhanced vasomotor tone and increased intrahepatic resistance (9, 7, 29) .
Despite the fact that bile acids are vasodilatory agents that accumulate in the body of patients with liver disorders, reaching concentrations up to 50 -60 M in patients with primary biliary cirrhosis (35) , whether GPBAR1 mediates vasodilation caused by individual bile acids has never been elucidated. Furthermore, since CSE-derived H 2 S exerts regulatory activities in the vasculature and GPBAR1 activity is modulated by endogenous H 2 S (2), we sought to investigate whether activa-tion of this receptor modulates the expression/activity of CSE in the endothelium (5, 12, 15, 22, 33) .
Our results demonstrate that LCA, a secondary bile acid and physiological ligand for GPBAR1, promotes a CSE-dependent vasodilation of conductance vessels (aortic rings), and that this effect is attenuated by GPBAR1 Ϫ/Ϫ gene ablation. These data are corroborated by the demonstration that 5␤-cholanic acid, a GPBAR1 antagonist, reverses vasodilation caused by LCA. Present findings provide a molecular support to the vasodilatory effects of secondary bile acids and might help to define novel therapeutic targets in patients with liver disorders and hyperdynamic circulation.
METHODS

Materials and Methods
Chemicals. Bile salts [DCA, CDCA, CA, LCA, hyocholic acid (HCA), taurolithocholic acid (TLCA), taurocholic acid (TCA), taurochenodeoxycholic acid (TCDCA), taurodeoxycholic acid (TDCA), taurohyocholic acid (THCA)], L-phenylephrine (PE), serotonin (5-HT), acetylcholine (ACh), norepinephrine (NE), the CSE inhibitor propargylglycine (PAG), the nitric oxide synthase inhibitor
, and the PI3 kinase inhibitor LY-294,002 were from Sigma Aldrich. 5␤-Cholanic acid was synthesized by Prof. Zampella (V. Sepe, B. Renga, C. Festa, C. Finamore, D. Masullo, A. Carino, S. Fiorucci, A. Zampella, unpublished observations).
Animals. GPBAR1 null mice (generated directly into C57BL/ 6NCrl background), and their congenic littermates on C57BL/6NCrl mice were kindly gifted by Dr. Galya Vassileva (Schering-Plough Research Institute, Kenilworth) (36) . Mice were housed under controlled temperatures (22°C) and photoperiods (12:12-h light/dark cycle), allowed unrestricted access to standard mouse chow and tap water, and allowed to acclimate to these conditions for at least 5 days before inclusion in an experiment. Authorization for animal handling was released from Ministero della Sanita, Italy, to Prof. Stefano Fiorucci, permit no. 245/2013-B.
Aortic rings preparation. Experiments on aortic rings were performed at the University of Naples. Male GPBAR1 ϩ/ϩ and GPBAR1 Ϫ/Ϫ mice of 8 -10 wk of age were euthanized, and the thoracic aorta was rapidly dissected and cleaned from fat and connective tissue. Rings of 2-3 mm length were cut and placed in organ baths (2-5 ml) filled with oxygenated (95% O 2-5% CO2) Krebs solution at 37°C and mounted to isometric force transducers (type 7006, Ugo Basile, Comerio, Italy) and connected to a Graphtec line recorder (WR 3310). The composition of the Krebs solution was as follows (mol/l): 0.118 NaCl, 0.0047 KCl, 0.0012 MgCl 2, 0.0012 KH2PO4, 0.0025 CaCl2, 0.025 NaHCO3, and 0.010 glucose. Rings were initially stretched until a resting tension of 0.5 g was reached and allowed to equilibrate for at least 30 min during which tension was adjusted, when necessary, to 0.5 g, and bathing solution was periodically changed. In a preliminary study, a resting tension of 0.5 g was found to develop the optimal tension to stimulation with contracting agents. In each experiment aortic rings were first challenged with PE (10 Ϫ6 mol/l) until the responses were reproducible. To verify the integrity of the endothelium, ACh cumulative concentration-response curve (from 10 Ϫ8 to 10 Ϫ5 M) was performed on PE contracted rings. Vessels that relaxed Ͻ85% were discarded.
In a separate set of experiments, aortic rings harvested from wild-type mice were denuded from endothelium by gently rubbing the internal surface of the vascular lumen. Rings were then challenged with PE (1 M) and once plateau was reached a cumulative concentration-response curve to CDCA, CA, and LCA (from 10 Ϫ8 to 10
Ϫ4
M) was performed.
To investigate the role of GPBAR1 in LCA-induced vasodilatation, aortic ring were incubated with 5␤-cholanic acid, a selective GPBAR-1 antagonist. Following PE-induced contraction, the cumulative concentration-response curve to LCA (from 10 Ϫ8 to 10 Ϫ4 M) was examined. Plasma bile acid determination. The stock solutions of the individual tauroconjugated and unconjugated bile acids were prepared separately in methanol at a concentration of 1 mg/ml. All stock solutions were stored at Ϫ20°C. Calibration standards were prepared by combining appropriate volumes of each bile acid stock solution and methanol. The calibration range was from 10 nmol/l to 100 mmol/l of each bile acid in the final solution. Serum sample aliquots of 100 l were deproteinized with 1 ml cold acetonitrile (ACN) with 5% NH 4OH, vortexing for 1 min. After centrifugation at 16,000 g for 10 min, the clear supernatant was transferred to a new vial, snapfrozen, and lyophilized. The sample was then redissolved in methanol and water [2:1 volume for volume (vol/vol)] for tauroconjugated bile acid determination and in methanol-ammonium acetate 10 mmol/l with 0.005% formic acid (3:2 vol/vol) for unconjugated bile acid determination. A bile acid extraction yield of 95% was measured with the addition of bile acid standard in plasma samples before and after the deproteinization procedure (25) .
Liquid chromatography and mass spectrometry. For liquid chromatography-tandem mass spectrometry (MS/MS) analysis, chromatographic separation was carried out on the LTQ XL high-performance liquid chromatography mass spectrometry system (ThermoScientific) equipped with the Accelera 600 Pump and Accelera AutoSampler system. The mixture was separated on a Jupiter 5 m C18 Å column (150 ϫ 2.00 mm) (Phenomenex). Tauroconjugated bile acids were separated at a flow rate of 200 l/min using a methanol-aqueous ammonium acetate (NH 4OAc) gradient. Mobile phase A was 5% methanol in water containing 2 mM ammonium acetate at pH 7; mobile phase B was methanol, containing ammonium acetate at 2 mM. The gradient started at 30% B and increased to 100% B in 20 min, kept at 100% B for 5 min, then decreased to 30% B in 1 min and kept at 30% B for 10 min. ESI was performed in negative ion mode; the ion source temperature was set at 280°C. The tune page parameters were automatically optimized injecting taurocholic acid at 1 M as standard. The MS/MS detection was operated in MRM mode using a collision energy of 20 (arbitrary units); the observed transitions were tauro-␤-muricholic acid (tbMCA) at 13. 29 Th. Unconjugated bile acids were separated at a flow rate of 200 l/min using 10 mM ammonium acetate in water at 0.005% formic acid as the mobile phase A, and 10 mM ammonium acetate in methanol at 0.005% formic acid as mobile phase B. The gradient program started at 60% B and increased to 95% B in 25 min, kept at 95% B for 9 min, then decreased to 60% B in 1 min and kept at 60% B for 10 min. ESI was performed in negative ion mode; the ion source temperature was set at 280°C. The tune page parameters were automatically optimized injecting CA at 1 M as standard. The MS/MS detection was operated in MRM mode using a collision energy of 15 (arbitrary units Total RNA was isolated from endothelial cells using the TRIzol reagent according to the manufacturer's specifications (Life Technologies). One microgram of RNA was purified from genomic DNA by DNase-I treatment (Life Technologies) and reverse-transcribed using random hexamer primers with Superscript-II (Life Technologies) in a 20-l reaction volume. Ten nanograms cDNA was amplified in a 20 l solution containing 200 nM of each primer and 10 l of KAPA SYBR FAST Universal qPCR Kit (KAPA BIOSYSTEMS). All reactions were performed in triplicate, and the thermal cycling conditions were as follows: 3 min at 95°C, followed by 40 cycles of 95°C for 15 s, 56°C for 20 s and 72°C for 30 s. The relative mRNA expression was calculated accordingly with the C t method. PCR primers were designed using the software PRIMER3 (http://frodo.wi.mit.edu/ primer3/) using published sequence data obtained from the NCBI database. Forward and reverse primer sequences were hGAPDH, gaaggtgaaggtcggagt and catgggtggaatcatattggaa; hCSE, cactgtccaccacgttcaag and gtggctgctaaacctgaagc; hCBS, tcgtgatgccagagaagatg and ttggggatttcgttcttcag; hTGR5, cactgttgtccctcctctcc and acactgctttggctgcttg; and heNOS, agtgaaggcgacaatcctgtat and agggacaccacgtcatactcat.
Western blotting. To investigate protein expression of GPBAR1 and CSE, HAEC and HUVEC cells serum starved O/N were stimulated with 10 M TLCA for 18 h. Total lysates were prepared by solubilization of endothelial cells in NuPage sample buffer (Life Technologies) containing Sample Reducing Agent (Invitrogen) and separated by PAGE. The proteins were then transferred to nitrocellulose membranes (Bio-Rad) and probed with primary antibodies CSE (Santa Cruz), GPBAR1/TGR5 (Abcam), tubulin (Sigma), phosphoAkt (Santa Cruz), Akt (Santa Cruz), and phospho-serine (Abcam). Nitrocellulose membranes were first probed with a phospho-serine antibody and then stripped and reprobed with the CSE antibody. Similarly, nitrocellulose membranes were first probed with the phospho-Akt antibody, stripped, and then reincubated with the Akt antibody. The anti-immunoglobulin G horseradish peroxidase conjugate (Bio-Rad) was used as the secondary antibody, and specific protein bands were visualized using Super Signal West Dura (Pierce), following the manufacturer's suggested protocol (30) .
CSE promoter analysis, plasmid construction, and luciferase assay. Human, murine, and rat proximal promoter regions of CSE gene were analyzed with the on-line software TFsearch (http://www. cbrc.jp/research/db/TFSEARCH.html) for searching of putative CREB consensus sequences. For luciferase assay, five tandem repeats of the putative CRE1 and CRE2 responsive sequences were cloned KpnI-XhoI into the pGL4 luciferase reporter vector. HEK-293T cells were transfected with 200 ng of pGL4(CRE1)5X or pGL4(CRE2)5X or with pGL4.29 (a reporter vector containing a canonical cAMP response element), with 100 ng of pCMVSPORT6-human GPBAR1 and with 100 ng of pGL4.70 (a vector encoding the human Renilla gene). Forty-eight hours posttransfection, cells were stimulated 18 h with a dose response of TLCA (1, 10, and 50 M). Control cultures received vehicle (0.1% DMSO) alone. Cells were lysed in 100 l diluted reporter lysis buffer (Promega), and 10 l of cellular lysate was assayed for luciferase activity using the Glomax 20/20 luminometer (Promega, Milan, Italy). Luciferase activities were normalized for transfection efficiencies by dividing the relative luciferase units (RLU) by Renilla activities (RRU).
CSE protein analysis. To identify potential phosphorylation sites on human, mouse, and rat CSE (CTH) proteins we used a PhosphoSite Plus (http://www.phosphosite.org) software, an open interactive resource for investigating experimentally posttranslational modifications. To predict which kinases may target particular Ser, Thr, or Tyr residues we used the on-line software Scansite3 (scansite3.mit.edu).
Immunoprecipitation. Overnight serum starved HUVECs were stimulated with TLCA (10 M) for 0, 5, 15, 30, and 60 min. After stimulation, cells were washed with cold PBS and lysed in 500 l E1A lysis buffer containing protease and phosphatase inhibitors. Lysates were sonicated and clarified by centrifugation at 13,000 g for 10 min, and the protein concentrations were determined by Bradford assay. Five-hundred micrograms total proteins were precleared on a rotating wheel for 1 h at 4°C using protein A Sepharose beads (Amersham Biosciences) and 1 g of irrelevant antibody of the same species and isotype as CSE. Immunoprecipitation was performed overnight at 4°C with 1 g CSE antibody (Santa Cruz) or anti-IgG as a negative control antibody in the presence of 40 l of protein A Sepharose (Amersham Biosciences). The resultant immunoprecipitates were washed five times with 1 ml of E1A lysis buffer and then used for Western blotting.
Chromatin immunoprecipitation. Serum starved HUVEC cells (10 ϫ 10 6 ) were stimulated 18 h with 10 M TLCA or received the vehicle alone (1% DMSO). Chromatin was immunoprecipitated with an anti-phosphoCREB antibody (Santa Cruz) or with an anti-IgG as negative control. Detailed methods for ChIP protocol and Real-Time data analysis have been previously described (30) . The sequences of primers used for the amplification of the human CRE1 and CRE2 promoter sequences were CRE1, ctggtctcgaactcttgacttcag and gctaacgcctattaatcccagcac; CRE2, gtggtctgtttacagttacccggt and tgccatgctggctcctgaga.
Electrophoretic mobility shift assay. Nuclear extracts from serum starved HUVEC cells left untreated or stimulated 18 h with TLCA (10 M) were prepared using the NE-PER kit (Pierce). Nuclear extracts (10 g) were incubated for 20 min at room temperature with 20 fmol of biotin-labeled CRE1 probe (GCCTTGACTTCATGCA) or with biotin-labeled CRE2 probe (GCCTTGAGGTCATGCA), prior to electrophoresis. For competition experiments, 250-fold excess of unlabeled probes or anti-phosphoCREB antibody (Santa Cruz) were incubated for 20 min with nuclear extracts from stimulated cells before addition of the biotin-labeled probes.
CSE activity. CSE activity was performed as previously described (29) . HUVEC and HAEC cells serum starved O/N were stimulated with 10 M TLCA for 18 h. To investigate on the role of PI3K/Akt in the regulation of CSE activity HUVEC cells serum starved O/N were stimulated for 18 h with 10 M TLCA or with the combination of TLCA plus LY-294,002 (10 M). To investigate the role of GPBAR1 in the regulation of CSE activity, HUVEC cells serum starved O/N were stimulated for 18 h with 10 M TLCA or with the combination of TLCA plus 5␤-cholanic acid (50 M).
Statistical analysis. All values are means Ϯ SE of number (n) of observations per group. Comparisons were made by one-way ANOVA with post hoc Tukey's test. Comparison of two groups was made by the Student's t-test for unpaired data when appropriate.
RESULTS
Vasoconstriction and Vasodilation in GPBAR1
Ϫ/Ϫ Mice
We have first characterized the liver and vascular phenotype of GPBAR1 Ϫ/Ϫ mice compared with their congenic littermates. GPBAR1 null mice had normal serum levels of AST but slight increase of bilirubin (Fig. 1, A and B) . The mean arterial pressure (MAP) was similar to that of congenic mice (Fig. 1C) . In contrast, quantitative analysis of serum bile acids revealed that GPBAR1 Ϫ/Ϫ mice had higher concentrations of circulating bile acids, reaching a value of ϳ200 M [ Fig. 1D , P Ͻ 0.05 vs. wild-type (WT) animals]. Analysis of individual bile acid species demonstrates that concentrations of nonconjugated (HCA, CA, CDCA, DCA, and LCA) and taurine-conjugated (T␤MCA, THCA, TCA, TCDCA, TDCA, and TLCA) bile acids were higher in mice harboring a disrupted GPBAR1 (Fig. 1, E and F (Fig. 1G ), GPBAR1 null mice had a robust increase of TCA (from 24% to 34%), as well as a decrease of CA (from 6 to 2%).
Vasodilation Induced by LCA is Impaired in GPBAR1
Ϫ/Ϫ Mice GPBAR1 gene ablation results in multiple functional alterations of conductance vessels. Indeed, as illustrated in Fig. 2 ,
A-C, aortic rings prepared from GPBAR1
Ϫ/Ϫ mice had a slight but significant impairment of the contractile response to PE but not to 5-HT (Fig. 2, A and B , P Ͻ 0.05 vs. WT animals). Furthermore, vasodilation caused by acetylcholine was slightly enhanced in animals harboring a disrupted GPBAR1 (Fig. 2C , P Ͻ 0.05 vs. WT animals). ϩ/ϩ , and GPBAR1 Ϫ/Ϫ mice. D: total plasma bile acids concentrations. E and F: plasmatic concentrations of nonconjugated (E) and conjugated (F) bile acids in GPBAR1 ϩ/ϩ and GPBAR1 Ϫ/Ϫ mice. G: qualitative analysis of serum bile acid composition in GPBAR1 ϩ/ϩ and GPBAR1 Ϫ/Ϫ mice. Data are means Ϯ SE of 8 mice per group. CA, cholic acid; LCA, lithocholic acid; DCA, deoxycholic acid; CDCA, chenodeoxycholic acid; HCA, hyocholic acid; tCA, taurocholic acid; tLCA, taurolithocholic acid; tDCA, taurodeoxycholic acid; tCDCA, taurochenodeoxycholic acid; tHCA, taurohyocholic acid; t␤MCA, tauro-␤-muricholic acid. GPBAR1, G protein-coupled bile acid receptor 1. *P Ͻ 0.05 vs. GPBAR1 ϩ/ϩ mice.
To investigate whether GPBAR1 mediates vasodilation caused by bile acids, we then assessed the vasomotor activity of individual bile acids using aortic rings prepared from wildtype and GPBAR1 Ϫ/Ϫ mice. As shown in Fig. 2, D and E, exposure of aortic rings to CDCA, CA, and DCA resulted in a robust vasodilation that was fully conserved in GPBAR1 Ϫ/Ϫ mice. However, aortic rings from GPBAR1 Ϫ/Ϫ mice displayed an attenuated vasodilatory response to LCA. Thus the EC 50 of LCA-induced vasodilation of PE-contracted rings increased ϳ3-fold from 34 to 84 M (Fig. 2, D and E, P Ͻ 0.05 vs. WT animals). Because the vasodilation caused by LCA appears to be partially dependent on a conserved GPBAR1 signaling, we then investigated downstream signals involved in this effect. As shown in Fig. 3, A and B , incubation of aortic rings with propargylglycine (PAG), a nonselective CSE inhibitor, abrogated the vasodilatory effect of LCA in GPBAR1 ϩ/ϩ mice but failed to reverse vasodilation caused by this agent in GPBAR1 null animals (Fig. 3, A and B , P Ͻ 0.05 vs. WT animals). Of interest, PAG had no effect on vasodilation induced by CDCA (Fig. 3C) .
In contrast to PAG, L-NIO, a nonselective eNOS inhibitor, had no effect on vasodilation induced by LCA in wild-type mice (Fig. 4A) . Because NO is known to mediate the endothelium-dependent vasodilation, we have further examined whether vasodilation caused by LCA was endothelium dependent by challenging endothelium-deprived aortic ring with primary and secondary bile acids. We have demonstrated the efficacy of endothelium deprivation procedure by generating a dose-response curve to acetylcholine (Fig. 4B) . Results shown in Fig. 4 , C-E, demonstrate that vasodilation caused by LCA was maintained in endotheliumdeprived aortic rings, thereby confirming results obtained with L-NIO (n ϭ 4) and indicating that vasodilatory action of bile acids is largely due to a direct interaction with smooth muscle cells.
Vasodilation caused by LCA was also resistant to iberiotoxin (100 nM) both in wild-type and GPBAR1
Ϫ/Ϫ mice, while vasodilation caused by CDCA was reduced by a coincubation with the calcium-activated large-conductance K channels (BK Ca ) inhibitor (Fig. 5, A and B) . ϩ/ϩ and GPBAR1 Ϫ/Ϫ mice. D and E: vasorelaxant effect of CDCA, CA, DCA, and LCA on aortic rings isolated from GPBAR1 ϩ/ϩ (E) and GPBAR1 Ϫ/Ϫ (F) mice. Data are means Ϯ SE of 8 mice per group. **P Ͻ 0.05 vs. GPBAR1 ϩ/ϩ mice; ***P Ͻ 0.01 vs. GPBAR1 ϩ/ϩ mice.
GPBAR1 Regulates CSE Expression/Activity in Human Endothelial Cells
Because these data demonstrate that vasodilation caused by LCA is eNOS independent but is reversed by PAG, a CSE inhibitor, in a GPBAR1-dependent manner, we sought to define the molecular mechanisms involved in this effect using human arterial and venular endothelial cells. First of all we have examined whether GPBAR1 deficiency results in dysregulated expression of CSE and eNOS in the aortas. However, as predicted by the fact that these mice had normal MAP, the expression of CSE and eNOS in the aortas along with circulating levels of H 2 S and nitrite/nitrate were similar to that of their congenic littermates (data not shown). Because GPBAR1 Ϫ/Ϫ mice had elevated levels of primary and secondary bile acids, that activate multiple BARs, making it difficult to dissect individual signals in these animals, we have further examined the role of GPBAR1 signaling using endothelial cells. Expression of GPBAR1 mRNA was detected in HAEC cells, and the stimulation of these cells with TLCA (10 M) induced the expression of CSE, mRNA, and protein, while no significant changes in the relative expression of CBS, eNOS, and GPBAR1 gene expression were detected (Fig. 6A , P Ͻ 0.05 vs. untreated cells). However, exposure to TLCA resulted in a time-dependent phosphorylation of eNOS (data not shown). Consistent with these results, CSE activity increased in HAEC treated with TLCA ( Fig. 6B , P Ͻ 0.05 vs. untreated cells). All together these results demonstrated that GPBAR1 activation by TLCA in HAEC cells results in a positive regulation of CSE expression/activity. These results were confirmed in human umbilical endothelial cells (HUVEC). In these cells, TLCA effectively induced both CSE mRNA and protein expression and increased CSE enzyme activity (Fig. 6, C and D) .
GPBAR1 Promotes the Recruitment of CREB to the CSE Promoter
Because GPBAR1 signals by recruiting the transcription factor CREB to CREB responsive elements (CRE) in the promoter of target genes, we have searched for putative CREs in the promoter of CSE. The analysis of the 5=-flanking region of human, mouse, and rat CSE gene revealed the presence of two conserved CRE, we named CRE1 and CRE2. In the human CSE promoter the CRE1 is located at Ϫ1,502 base pairs (bp) with respect to the transcriptional starting site ATG, while the CRE2 is located at Ϫ467 bp (Fig. 7A) . To explore the functionality of these putative CREs in regulating the CSE expression, five copies of the CRE1 and CRE2 were cloned in a pGL4 vector and transfected into HEK293T cells also transiently transfected with GPBAR1. The luciferase reporter assay results shown in Fig. 7, B-D , demonstrated that the activation of these two CREs by TLCA was concentration-dependent and required 50 and 10 mol/l TLCA, respectively, for CRE1 and CRE2. To verify the hypothesis that CREB binds the putative CREs in the CSE promoter, we then performed an EMSA experiment using biotin-labeled probes against CRE1 and CRE2. These probes were incubated with nuclear extracts from HUVEC cells not treated or stimulated with TLCA. As shown in Fig. 7 , E and F, a slight supershift was observed when CRE1 and CRE2 probes were incubated with nuclear extracts from naive cells while the exposure to TLCA strongly induced these interactions (Fig. 7E, lanes 2 and 3; Fig. 7F, lanes 2 and 3) . We confirmed the specificity of these interactions by adding 250-fold excess of unlabeled CRE1 and CRE2 probes or 1 g anti-phospho-CREB antibody (Fig. 7E, lanes 4 and 5; Fig. 7F,  lanes 4 and 5) . Furthermore, results from CHIP experiment shown in Fig. 7 , G and H, confirmed that CREB binds the CSE promoter in basal conditions on both CRE1 and CRE2 and that these interactions were strongly enhanced in cells exposed to TLCA. Thus the functionality of the two CREs sites was confirmed in the context of intact chromatin structures.
GPBAR1 Promotes Protein Phosphorylation and Increases CSE Activity
Because effects exerted by LCA in aortic rings bath are more compatible with rapid activation of CSE rather than gene regulation, we have examined whether LCA exerts nongenomic effects on CSE. One such regulatory pathway, similarly to eNOS, could be protein phosphorylation. Theoretical prediction of phosphorylation sites on CSE protein sequence was performed using PhosphoSite Plus and Scansite3 software. As shown in Fig. 8A , PhosphoSite Plus predicted a total of 10 conserved phosphorylation sites in human, mouse, and rat CSE protein corresponding to Ser8, Ala51, Tyr60, Tyr114, Ile140, Thr158, Thr160, Thr163, Ser282, and Ser377 residues of human CSE protein. To understand which kinases might phosphorylate these sites we have applied to human CSE the Scansite algorithm, which uses position-specific scoring matrices (PSSMs) for 32 kinases, including a set of PSSMs for several mitotic kinases. The analysis of phosphorylation sites predicted by Scansite at high stringency is shown in Table 1 .
Of note, comparison of the Scansite motifs matched to the sites within our dataset with all phosphorylation sites present in the PhosphoSitePlus database, revealing that Ser377 may be a substrate for AKT1 and cAMP dependent protein kinase PKACG, two downstream signals triggered by GPBAR1. To validate our bioinformatic analysis we next performed immunoprepitation experiments. We first subjected HUVEC cells to time course treatment with TLCA to evaluate the phosphorylation status of Akt. As shown in Fig. 8B we found that exposure to TLCA increases the level of phosphorylated Akt1 protein within 5 min of treatment, and this activation was maintained until 60 min (Fig. 8B) . The effect of GPBAR1 activation on phosphorylation status of CSE protein was quantified by immunoprecipitation with an anti-CSE antibody followed by Western blot analysis using an anti-phosphoserine, anti-Akt1, and anti-phospho-Akt1 antibodies. Results from immunoprecipitation experiments demonstrated the existence of a protein complex between the proteins CSE and Akt1 which is clearly assembled already in basal conditions (Fig.  8C) . Of interest, the interaction between CSE and Akt1 (both phosphorylated or total) in HUVEC increased after 5 min stimulation with TLCA (Fig. 8C) . Moreover, 30 min treatment with TLCA increased the phosphorylation of CSE on serine residues without affecting total CSE protein levels (Fig. 8C) .
Finally, to further demonstrate the role of PI3K/Akt in mediating CSE phosphorylation, HUVEC were coincubated with a PI3K kinase inhibitor, LY-294,002. Results from enzyme activity assay demonstrated that pretreating HUVEC with LY-294,002 resulted in a significant reduction of TLCA-mediated activation of CSE activity (Fig. 8D) .
GPBAR1 Antagonism by DFN406 Locks Vasodilatory Effect of LCA
To further tie activation of GPBAR1 to CSE activity in HUVEC cells, we then carried out experiments using a GPBAR1 antagonist. As shown in Fig. 9A , incubation of aortic rings with 5␤-cholanic acid, a GPBAR1 antagonist, significantly reduced LCA-induced vasodilatation, suggesting that GPBAR1 activation contributes to the vasodilatory action of LCA observed in this study. In addition, results from both RT-PCR and enzyme activity assay demonstrated that the pretreatment of HUVEC with DFN406 attenuates regulation of CSE (mRNA expression and enzyme activity) caused by TLCA (Fig. 9, B and C) .
DISCUSSION
Patients with liver cirrhosis and portal hypertension develop hypotension and attenuated vascular tone, which has been associated to a NO-dependent impairment of peripheral vascular responses (4, 31) , leading to a hyperdynamic circulation. Despite that this syndrome might have several mechanistic explanations, it is well understood that, as liver disease progresses toward cirrhosis, the bile acid pool shifts from the enterohepatic to the systemic circulation (13, 26) . This increased concentration of bile acids might be a causative factor in the pathogenesis of the hyperdynamic state occurring in the end stage of liver disorders (4) .
By using mice that were deficient for GPBAR1 (36), we have now shown that vasodilation caused by primary and secondary bile acids occurs through a GPBAR1-dependent mechanisms. Additionally, we have provided evidence that GPBAR1 activation regulates the expression/activity of CSE, an enzyme that is critical for the generation of H 2 S, and that CSE inhibition caused by PAG reverses the vasodilatory effect exerted by LCA (and TLCA) in wild-type mice, but not in GPBAR1 Ϫ/Ϫ mice. GPBAR1 is expressed in the vascular system. However, GPBAR1 Ϫ/Ϫ mice do not develop overt alterations in their vascular phenotype and have a normal MAP despite the fact that circulating bile acids were significantly higher than that of their congenic littermates. Furthermore, results from ex vivo experiments carried out using aortic rings demonstrate that vasodilation caused by primary bile acids is maintained in GPBAR1 Ϫ/Ϫ mice. Only vasodilation caused by LCA, a potent GPBAR1 ligand, was significantly reduced by the ablation of the receptor as demonstrated by a 3-fold increase in EC 50 required by LCA to elicit a full vasodilatory response. Because vasodilation caused by primary bile acids, CDCA and CA, was maintained in GPBAR1 Ϫ/Ϫ mice it appears that GPBAR1-independent mechanisms mediate the activity of these bile acids. Importantly, CDCA and CA are poor ligands for GPBAR1. Indeed, the EC 50 required for GPBAR1 activation in CHO cells transfected with GPBAR1 (TGR5) by TLCA, LCA, DCA, CDCA, and CA was reported to be 0.33, 0.53, 1.01, 4.43, and 7.72 m, respectively (13) . Further, in addition to GPBAR1, CDCA and CA activate a number of receptors/ channels including FXR and BK Ca (8) , type 3 of muscarinic receptor (16) , and K ATP channels via a cAMP-protein kinase A-dependent mechanism (18) . Activation of these receptors and channels might explain the fact that vasodilation caused by CDCA and CA is maintained in GPBAR1 Ϫ/Ϫ mice. Vice versa, because LCA and DCA also activate these receptors, although with a different rank of potencies, it appears difficult to dissect individual pathways in vivo, when multiple bile acid species are present.
Because vasodilation caused by LCA was attenuated by GPBAR1 gene ablation we have focused our attention on the mechanisms that support this effect. Data shown in Fig. 3 demonstrate that while vasodilation caused in wild-type mice by LCA is blunted by exposure to PAG, an inhibitor of CSE activity (1), this inhibitory effect was lost in GPBAR1 Ϫ/Ϫ mice, thereby establishing that, at least in naive mice, vasodilation caused by LCA implies a GPBAR1/CSE-mediated pathway.
An important finding we made in this study was that vasodilation caused by bile acids was maintained in aortic rings denuded from endothelium. This observation along with the fact that L-NIO, a selective inhibitor of eNOS, had no detectable effect on vasodilation caused by LCA in wild-type mice, despite that LCA induces in vitro phosphorylation of eNOS (data not shown), support the notion that GPBAR1-mediated vasodilatory effect are only in part due to the activation of endothelium. Indeed, Rajagopal et al. (27) have shown that GPBAR1 is expressed by and regulates smooth muscle cell relaxation via both Epac-and PKA-mediated inhibition of the RhoA/Rho kinase pathway. Furthermore, vasodilation caused by LCA was iberiotoxinresistant in both wild-type and GPBAR1 Ϫ/Ϫ mice, thus indicating that LCA induces a vasodilation through a BK Caindependent and GPBAR1/CSE-mediated mechanism in wildtype mice. In contrast, vasodilation caused by CDCA was iberiotoxin sensitive, thereby suggesting that this bile acid activates BK Ca channels. Our observation is consistent with the findings that in dogs, vasodilation caused by synthetic GPBAR1 ligands is only partially sensitive to iberiotoxin (12) . The fact that L-NIO failed to attenuate vasodilation caused by LCA, despite that it causes the phosphorylation of eNOS, is also consistent with the observation that L-NAME does not attenuate vasodilation caused by synthetic GPBAR1 ligands in dogs (12) .
CREB is a cyclic AMP response element (CRE)-binding protein activated following GPBAR1 ligation by bile acids (32) . In the present study we have identified two CRE sequences in the promoter of CSE (28) . The CRE elements are conserved across species, and their functionality was confirmed by a variety of molecular approaches in HUVEC. Thus, by luciferase reporter gene assays, we have observed that GPBAR1 activation by TLCA increases the transcriptional activity on human CSE promoter, while chromatin immunoprecipitation experiments have provided robust evidence that GPBAR1 activation recruits CREB in its active form to the human region of CSE promoter that contains the two CREB binding sites. Finally, results of EMSA experiments confirmed that the transcription factor CREB binds to both proximal and distal CRE sequences and that the incubation of nuclear extracts with a specific antibody directed against the active form of CREB abrogates the binding of nuclear extracts to the CRE1 or CRE2 biotin-labeled probes. Taken together these results provide a molecular explanation to the potent inhibitory effect exerted by PAG on vasodilation caused by LCA.
GPBAR1 signals through the activation of cAMP/PKA and PI3K/Akt pathways (17, 27) . Analysis of putative phosphorylation sites of CSE performed with PhosphoSite plus software and Scansite algorithm revealed that this enzyme might be phosphorylated by Akt and cAMP-dependent PKA on serine resides, in particular Ser377. Western blotting and immunoprecipitate experiments have confirmed that TLCA increases Akt phosphorylation and results in a significant increase in CSE phosphorylation on serine residues. To support this observation, experiments conducted in HUVEC demonstrated that CSE activity was abrogated in cells coadministered with TLCA and LY-294,002, a PI3K inhibitor. The role of GPBAR1 in regulation of CSE was further demonstrated by the finding that GPBAR1 antagonism by 5␤-cholanic acid abrogates vasodilation-reversed CSE activation caused by TLCA. The fact that GPBAR1 gene deletion had no effect on aortic expression of CSE and eNOS mRNAs (data not shown) should be interpreted taking into account that GPBAR1 gene ablation alters bile acid metabolism, resulting in elevated levels of primary and secondary bile acids, which activate multiple receptors, a conundrum that is inherent to the model and to the pleiotropic function of each bile acid.
The present findings have clinical relevance since patients with liver disorders are characterized by altered systemic circulation. This vasodilatory syndrome results in an enhanced risk of fatal complications, and its pathogenesis is controversial. We have now provided evidence that circulating bile acids acting on endothelial and muscular receptors might play a mechanistic role. The fact that a GPBAR1 antagonist blunts the vasodilatory effect caused by TLCA paves the way for development of novel therapies.
In conclusion, we have demonstrated that primary and secondary bile acids are vasodilatory agents and that vasodilation induced by LCA is GPBAR1 dependent and involves the regulation of CSE expression/activity in endothelial and muscular cells. Despite that primary and secondary bile acids activate a variety of receptors and mediators, the present findings might help to interpret the systemic hemodynamic changes in patients with liver cirrhosis.
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